Advisory Advocates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Sell
1,088
-298
-22% -$143K 0.47% 76
2026
Q1
$681K Sell
1,386
-139
-9% -$75.4K 0.7% 48
2025
Q4
$884K Buy
+1,525
New +$862K 0.88% 33

Other funds holding TMO

Advisory Advocates's TMO Position: Q2 2026 in Review

Advisory Advocates reduced its Thermo Fisher Scientific (TMO) stake by 22% in Q2 2026, selling an estimated $143K and leaving 1,088 shares worth $546K. The position accounts for 0.47% of the portfolio, ranked #76.

Advisory Advocates first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $884K in Q4 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Advisory Advocates held 1,088 shares of Thermo Fisher Scientific worth $546K as of Q2 2026.
  • Advisory Advocates sold 298 Thermo Fisher Scientific shares in Q2 2026, an estimated $143K.
  • Thermo Fisher Scientific made up 0.47% of Advisory Advocates's portfolio in Q2 2026, its #76 holding.
  • Advisory Advocates first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Advisory Advocates's Thermo Fisher Scientific position peaked at $884K in Q4 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.